Malignant Nervous System Neoplasm — Trials

Malignant Nervous System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

3,459 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 954
Recruiting: 528
Ph III recruiting: 35
Growth YoY: +13%
Industry share: 15%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (494)

clinicaltrialsPublishedShowing 601–650 of 1,398 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03243851	Study on Low Dose Temozolomide Plus Metformin or Placebo in Patient With Recurrent or Refractory Glioblastoma(METT)	completed	Phase 2	81	Yong-Kil HongOTHER	1	Sep 9, 2021	clinicaltrials
NCT04351035	National Wide Cross-sectional Study in Paediatric Central Nervous System Tumours in China -- the CNOG-MC001 Registry	completed	—	4,303	Xinhua Hospital, Shanghai Jiao Tong University School of MedicineOTHER